• Sun, February 23, 2025
  • Fri, February 28, 2025
  • Sat, March 1, 2025

Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other pharmaceutical stocks.
The article from MSN Money discusses Merck & Co., Inc. (MRK) as one of the undervalued pharmaceutical stocks recommended for investment by analysts. It highlights that despite a year-to-date decline in stock value, Merck has shown robust performance with a significant increase in its stock price over the past year. The company's growth is attributed to its strong portfolio of drugs, particularly Keytruda, which continues to drive sales. Additionally, Merck's pipeline includes promising new treatments, and its strategic acquisitions are expected to bolster future growth. Analysts have set a price target suggesting potential upside, making Merck an attractive option for investors looking for value in the pharmaceutical sector. The article also mentions other pharmaceutical companies like Pfizer and Bristol-Myers Squibb, but focuses on Merck's potential due to its current valuation and future prospects.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/other/merck-co-inc-mrk-among-the-cheap-pharmaceutical-stocks-to-buy-according-to-analysts/ar-AA1zC875

Like: 👍